Lv2
170 积分 2023-09-25 加入
Targeted glycan degradation potentiates the anticancer immune response in vivo
13天前
已完结
IL-27 elicits a cytotoxic CD8+ T cell program to enforce tumour control
1个月前
已完结
Universal recording of immune cell interactions in vivo
1个月前
已完结
Brusatol improves the efficacy of an anti-mouse-PD-1 antibody via inhibiting programmed cell death 1 ligand 1 expression in a murine head and neck squamous cell carcinoma model
3个月前
已完结
A new PD-1-specific nanobody enhances the antitumor activity of T-cells in synergy with dendritic cell vaccine
3个月前
已完结
Genetic-code-expanded cell-based therapy for treating diabetes in mice
3个月前
已完结
Discovery of novel EGFR-PROTACs capable of degradation of multiple EGFR-mutated proteins
3个月前
已完结
In vivo AAV–SB-CRISPR screens of tumor-infiltrating primary NK cells identify genetic checkpoints of CAR-NK therapy
3个月前
已完结
On guard—activating NK cell receptors
3个月前
已完结
Development of selective FGFR1 degraders using a Rapid synthesis of proteolysis targeting Chimera (Rapid-TAC) platform
4个月前
已完结
皖公网安备34019202002308
